Author's reply to: Effect of adjuvant treatment on survival in 2023 FIGO stage IIC endometrial cancer

J Gynecol Oncol. 2024 May;35(3):e88. doi: 10.3802/jgo.2024.35.e88. Epub 2024 Apr 1.

Authors

Yoo-Young Lee^#¹, Yu-Li Chen^#², Yen-Ling Lai^{2

3}

Affiliations

¹ Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
² Department of Obstetrics and Gynecology, College of Medicine, National Taiwan University, Taipei, Taiwan.
³ Department of Obstetrics and Gynecology, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu, Taiwan. adina@kimo.com.

^# Contributed equally.

No abstract available

Publication types

Letter
Comment

MeSH terms

Chemotherapy, Adjuvant
Endometrial Neoplasms* / drug therapy
Endometrial Neoplasms* / mortality
Endometrial Neoplasms* / pathology
Endometrial Neoplasms* / therapy
Female
Humans
Neoplasm Staging*